| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1586/ERN.10.200 |
| P698 | PubMed publication ID | 21306210 |
| P50 | author | Mitchell S V Elkind | Q90764032 |
| Mira Katan | Q51001422 | ||
| P2860 | cites work | Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association | Q22241929 |
| Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association | Q22306345 | ||
| Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome | Q24794415 | ||
| Pathobiology of ischaemic stroke: an integrated view | Q28141682 | ||
| Pulsatile fluctuations of plasma-gonadotropin-releasing hormone and corticotropin-releasing factor levels in healthy pregnant women. | Q52378986 | ||
| Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma. | Q52947327 | ||
| Inflammatory markers and in-hospital mortality in acute ischaemic stroke. | Q53557864 | ||
| Midregional Pro-Atrial Natriuretic Peptide and Outcome in Patients With Acute Ischemic Stroke | Q57759267 | ||
| Prognostic Value of Copeptin | Q57759280 | ||
| Serum-cortisol reflects severity and mortality in acute stroke | Q44714156 | ||
| Progression in lacunar stroke is related to elevated acute phase parameters | Q44779532 | ||
| Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study | Q44799903 | ||
| Lateralization in autonomic dysfunction in ischemic stroke involving the insular cortex | Q44839050 | ||
| An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis | Q44865641 | ||
| Inflammatory biomarkers in blood of patients with acute brain ischemia | Q44894573 | ||
| Elevated C-reactive protein and long-term mortality after ischaemic stroke: relationship with markers of endothelial cell and platelet activation | Q45118321 | ||
| Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study | Q45256250 | ||
| Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment. | Q45881740 | ||
| Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke. | Q46023236 | ||
| Monocytes are major players in the prognosis and risk of infection after acute stroke | Q46150742 | ||
| Defining the proinflammatory phenotype using high sensitive C-reactive protein levels as the biomarker | Q46159301 | ||
| High plasma glutamate concentrations are associated with infarct growth in acute ischemic stroke. | Q46275766 | ||
| Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial | Q46414622 | ||
| Immuno-inflammatory and thrombotic/fibrinolytic variables associated with acute ischemic stroke diagnosis. | Q46420379 | ||
| Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients | Q46515718 | ||
| Hemostatic markers of recanalization in patients with ischemic stroke treated with rt-PA. | Q46641059 | ||
| Associations of inflammatory and hemostatic variables with the risk of recurrent stroke. | Q46693663 | ||
| Severity of leukoaraiosis and susceptibility to infarct growth in acute stroke | Q46702521 | ||
| Conversion of ischemic brain tissue into infarction increases with age. | Q46790556 | ||
| Plasma thrombosis markers following cerebral infarction in African Americans | Q46815319 | ||
| Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study | Q46825104 | ||
| Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study | Q46862725 | ||
| Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke. | Q47421490 | ||
| Lipoprotein-associated phospholipase A2 and C-reactive protein for risk-stratification of patients with TIA. | Q47747941 | ||
| Tumor necrosis factor-alpha expression in ischemic neurons | Q48094066 | ||
| Influence of arterial input function on hypoperfusion volumes measured with perfusion-weighted imaging | Q48118554 | ||
| Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions in hyperacute stroke. | Q48121709 | ||
| Predictive variables for mortality after acute ischemic stroke | Q48195369 | ||
| Catecholamines, infection, and death in acute ischemic stroke | Q48356852 | ||
| Infarct volume on apparent diffusion coefficient maps correlates with length of stay and outcome after middle cerebral artery stroke. | Q48359918 | ||
| The real estate factor: quantifying the impact of infarct location on stroke severity | Q48360959 | ||
| Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke | Q48371010 | ||
| High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke | Q48389128 | ||
| Immunoinflammatory activation during the acute phase of lacunar and non-lacunar ischemic stroke: association with time of onset and diabetic state. | Q48402518 | ||
| Blood glucose, glycosylated haemoglobin, and outcome of ischemic brain infarction | Q48450525 | ||
| Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications | Q48452238 | ||
| Identification of novel brain biomarkers. | Q48466456 | ||
| Role of fibrinogen levels and factor XIII V34L polymorphism in thrombolytic therapy in stroke patients | Q48466483 | ||
| Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke | Q48475070 | ||
| Plasma levels of inflammatory and thrombotic/fibrinolytic markers in acute ischemic strokes: relationship with TOAST subtype, outcome and infarct site | Q48479997 | ||
| Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke. | Q48504441 | ||
| Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke. | Q48527561 | ||
| High blood pressure and inflammation are associated with poor prognosis in lacunar infarctions | Q48543630 | ||
| B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failure | Q48591124 | ||
| Midregional pro-A-type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short-of-breath patients: comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP. | Q48615224 | ||
| Neuroanatomic correlates of stroke-related myocardial injury. | Q48624141 | ||
| Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke | Q48691904 | ||
| Is plasma fibrinogen useful in evaluating ischemic stroke patients?: why, how, and when. | Q48696602 | ||
| Inflammatory and hemostatic biomarkers associated with early recurrent ischemic lesions in acute ischemic stroke | Q48715096 | ||
| Inflammation markers and prediction of post-stroke vascular disease recurrence: the MITICO study. | Q48720131 | ||
| Mechanisms of C-reactive protein-induced blood-brain barrier disruption | Q48723368 | ||
| Hypercortisolism after stroke--partly cytokine-mediated? | Q48762561 | ||
| PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke | Q48788452 | ||
| Immunohistochemistry of atrial natriuretic peptide in brain infarction | Q48825813 | ||
| S100beta as a predictor of brain metastases: brain versus cerebrovascular damage | Q48841414 | ||
| A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke | Q48860420 | ||
| Increases in tumor necrosis factor-alpha following transient global cerebral ischemia do not contribute to neuron death in mouse hippocampus | Q48871169 | ||
| IL-6: an early marker for outcome in acute ischemic stroke | Q48899503 | ||
| Urinary free cortisol excretion shortly after ischaemic stroke | Q48920893 | ||
| Pro-inflammatory and anti-inflammatory cytokines in acute ischemic stroke and their relation to early neurological deficit and stroke outcome | Q48921136 | ||
| Increased levels of soluble tumor necrosis factor receptors in atherosclerosis: no clear relationship with levels of tumor necrosis factor. | Q50860140 | ||
| Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members | Q28175021 | ||
| Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5113 patients with transient ischemic attack and minor ischemic stroke | Q28212225 | ||
| Inflammation, cell adhesion molecules, and stroke: tools in pathophysiology and epidemiology? | Q28221303 | ||
| Physiology and neurobiology of stress and adaptation: central role of the brain | Q28235550 | ||
| Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans | Q28250065 | ||
| Tumor necrosis factor receptor levels are associated with carotid atherosclerosis | Q28344629 | ||
| Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond | Q29614697 | ||
| Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association | Q30434464 | ||
| Social stress exacerbates stroke outcome by suppressing Bcl-2 expression | Q30539704 | ||
| Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor | Q30829120 | ||
| Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. | Q30878935 | ||
| Predictive value of ischemic lesion volume assessed with magnetic resonance imaging for neurological deficits and functional outcome poststroke: A critical review of the literature | Q31073230 | ||
| MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke. | Q33322709 | ||
| Plasma brain natriuretic peptide as a surrogate marker for cardioembolic stroke | Q33392414 | ||
| Vascular MMP-9/TIMP-2 and neuronal MMP-10 up-regulation in human brain after stroke: a combined laser microdissection and protein array study. | Q33421471 | ||
| Modeling cerebral ischemia in neuroproteomics | Q33522645 | ||
| Imaging mass spectrometry revealed the production of lyso-phosphatidylcholine in the injured ischemic rat brain | Q33548977 | ||
| Lipoprotein-associated phospholipase A2 activity and risk of recurrent stroke | Q33756465 | ||
| Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies | Q33829154 | ||
| Dual role of tumor necrosis factor alpha in brain injury | Q33879032 | ||
| The Levels of Inflammatory Markers in the Treatment of Stroke study (LIMITS): inflammatory biomarkers as risk predictors after lacunar stroke | Q34054032 | ||
| The science of stroke: mechanisms in search of treatments | Q34212337 | ||
| Gene expression profiling of blood for the prediction of ischemic stroke | Q34330510 | ||
| The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis | Q34350872 | ||
| Natriuretic peptides and mortality after stroke | Q34407855 | ||
| Multiple biomarkers for the prediction of first major cardiovascular events and death | Q34593507 | ||
| Fibrinogen and lipid concentrations as risk factors for transient ischaemic attacks and minor ischaemic strokes | Q35180922 | ||
| The pathophysiological role of cytokines. | Q35205342 | ||
| Raised plasma oxidised LDL in acute cerebral infarction | Q35472283 | ||
| A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients | Q35484320 | ||
| Generation of C-reactive protein and complement components in atherosclerotic plaques | Q35746446 | ||
| Vasopressinergic regulation of the hypothalamic pituitary adrenal axis and stress adaptation | Q35932050 | ||
| Endocrinology of the stress response. | Q36041015 | ||
| Markers of inflammation and their clinical significance | Q36095131 | ||
| Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice | Q36109567 | ||
| Interleukin-1 and neuronal injury | Q36202191 | ||
| C-reactive protein is produced by a small number of normal human peripheral blood lymphocytes | Q36352119 | ||
| C-reactive protein in atherosclerosis: A causal factor? | Q36453512 | ||
| Circulating endothelial cells in cardiovascular disease | Q36625620 | ||
| A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window | Q36678875 | ||
| The inflammatory response in stroke | Q36692346 | ||
| Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. | Q36719103 | ||
| The brain-heart connection | Q36868231 | ||
| The parvocellular vasopressinergic system and responsiveness of the hypothalamic pituitary adrenal axis during chronic stress | Q36877195 | ||
| Inflammation in acute ischemic stroke and its relevance to stroke critical care. | Q37035033 | ||
| Improving outcome after stroke: overcoming the translational roadblock | Q37091669 | ||
| Bioassay research methodology: measuring CRH in pregnancy | Q37118494 | ||
| Is D-dimer helpful in evaluating stroke patients? A systematic review. | Q37244277 | ||
| The potential role of carbon dioxide in the neuroimmunoendocrine changes following cerebral ischemia | Q37244812 | ||
| Lipoprotein-associated phospholipase A2 and high-sensitivity C-reactive protein improve the stratification of ischemic stroke risk in the Atherosclerosis Risk in Communities (ARIC) study | Q37264593 | ||
| C-reactive protein and coronary heart disease: a critical review | Q37281648 | ||
| Molecular biomarkers in stroke diagnosis and prognosis | Q37408830 | ||
| Hyperfibrinogenemia and functional outcome from acute ischemic stroke | Q37414498 | ||
| Blood markers for the prognosis of ischemic stroke: a systematic review | Q37415033 | ||
| Clinical application of blood biomarkers in cerebrovascular disease | Q37688066 | ||
| Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study | Q38317059 | ||
| Glucocorticoid hypersecretion and the age-impaired hippocampus: cause or effect? | Q40447929 | ||
| Admission fibrinolytic profile is associated with symptomatic hemorrhagic transformation in stroke patients treated with tissue plasminogen activator. | Q40497898 | ||
| The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation | Q40506162 | ||
| Hypercortisolemia in acute stroke is related to the inflammatory response | Q40584312 | ||
| Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. | Q40607050 | ||
| Plasma catecholamines--analytical challenges and physiological limitations | Q40905051 | ||
| A comparison of goodness-of-fit tests for the logistic regression model | Q41478583 | ||
| Glucocorticoids and immune function: unknown dimensions and new frontiers | Q41591663 | ||
| Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones | Q41784037 | ||
| Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? | Q42943930 | ||
| Neuroendocrinology of post-traumatic stress disorder | Q43028514 | ||
| Editorial: why inhibition of lipoprotein-associated phospholipase A2 has the potential to improve patient outcomes | Q43059247 | ||
| Circadian secretion pattern of copeptin, the C-terminal vasopressin precursor fragment | Q43088389 | ||
| Copeptin: a novel, independent prognostic marker in patients with ischemic stroke | Q43207505 | ||
| Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. | Q43529232 | ||
| Associations of proinflammatory cytokines with the risk of recurrent stroke | Q43546564 | ||
| Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones | Q43580795 | ||
| Prediction of long-term functional outcome in patients with acute ischemic non-embolic stroke. | Q43885409 | ||
| Inflammation-mediated damage in progressing lacunar infarctions: a potential therapeutic target | Q43948946 | ||
| Plasma concentrations of brain natriuretic peptide in patients with acute ischemic stroke | Q43956913 | ||
| Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients | Q44053916 | ||
| N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes | Q44446907 | ||
| P433 | issue | 2 | |
| P921 | main subject | inflammation | Q101991 |
| biomarker | Q864574 | ||
| P304 | page(s) | 225-239 | |
| P577 | publication date | 2011-02-01 | |
| P1433 | published in | Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders | Q15760319 |
| P1476 | title | Inflammatory and neuroendocrine biomarkers of prognosis after ischemic stroke | |
| P478 | volume | 11 |
| Q33967122 | BNP but Not s-cTnln is associated with cardioembolic aetiology and predicts short and long term prognosis after cerebrovascular events |
| Q34261476 | Biomarker discovery in serum from patients with carotid atherosclerosis |
| Q38931129 | Blood/Brain Biomarkers of Inflammation After Stroke and Their Association With Outcome: From C-Reactive Protein to Damage-Associated Molecular Patterns. |
| Q34521252 | Factors Associated With New-Onset Depression After Stroke |
| Q58764705 | Inflammasome Proteins in Serum and Serum-Derived Extracellular Vesicles as Biomarkers of Stroke |
| Q41958830 | Inflammation, vasospasm, and brain injury after subarachnoid hemorrhage |
| Q40635905 | Inflammatory Biomarkers in Childhood Arterial Ischemic Stroke: Correlates of Stroke Cause and Recurrence |
| Q38270771 | Neuroendocrine hormones as prognostic biomarkers in the setting of acute stroke: overcoming the major hurdles. |
| Q38352188 | Neuroprotective actions of thyroid hormones and low-T3 syndrome as a biomarker in acute cerebrovascular disorders |
| Q35204568 | One is the deadliest number: the detrimental effects of social isolation on cerebrovascular diseases and cognition |
| Q43901436 | Prognostic value of plasma neuroendocrine biomarkers in patients with acute ischaemic stroke |
| Q47413931 | Prognostic value of thyroid hormones in acute ischemic stroke - a meta analysis |
| Q48199686 | Relationship of serum magnesium concentration to risk of short-term outcome of acute ischemic stroke |
| Q34998508 | Retracted: Cortisol as a Prognostic Marker of Short-Term Outcome in Chinese Patients with Acute Ischemic Stroke |
| Q38178714 | The role of neuroendocrine pathways in prognosis after stroke |
Search more.